Effentora

Effentora is a buccal film containing fentanyl citrate, used for managing breakthrough pain in adults already on opioid therapy. This fast-acting medication is designed for oral mucosal application.

Effentora is primarily used for the management of breakthrough pain in adults who are already receiving opioid therapy for chronic pain. It is not intended for initial pain management or for use in opioid-naive patients. The buccal film is applied to the inner lining of the cheek, where it dissolves to deliver fentanyl citrate for rapid pain relief.

Common effects of Effentora may include drowsiness, dizziness, nausea, and headache. Some users may experience constipation or dry mouth. These effects can vary depending on individual tolerance and the severity of the pain being managed.

Effentora should be handled with care, as fentanyl citrate is a potent opioid. It should be stored securely to prevent accidental exposure, especially by children or pets. Users should avoid driving or operating heavy machinery until they know how the medication affects them.

Effentora may interact with other medications, including other opioids, benzodiazepines, and certain antidepressants. Alcohol should be avoided while using Effentora, as it can enhance the sedative effects. Always consult a healthcare provider before combining Effentora with other medications.